Clinical Pipeline
Multiple preclinical studies and clinical trials are in progress worldwide using Polyplus’ transfection® reagents for Human Cancer Therapy and HIV Immune Therapy.
An overview of the current trials and studies pipeline is detailed below. These preclinical studies and clinical trials are conducted by Polyplus customers’ with batches of GLP and cGMP in vivo-jetPEI®transfection reagent supplied by Polyplus. Unfortunately, a full description of the current projects is not available due to confidentiality. However, additional information is available on the clinical trial sponsors’ web sites.
Multiple preclinical studies and clinical trials are in progress worldwide using Polyplus’ transfection reagents for Human Cancer Therapy and HIV Immune Therapy.
An overview of the current trials and studies pipeline is detailed below. These preclinical studies and clinical trials are conducted by Polyplus customers’ with batches of GLP and cGMP in vivo-jetPEI™ transfection reagent supplied by Polyplus. Unfortunately, a full description of the current projects is not available due to confidentiality. However, additional information is available on the clinical trial sponsors’ web sites.
*Project developed with in vivo-jetPEI®-Man
